The PEAR Study A Phase 1 Dose Escalation of Pembrolizumab Given Concurrently with Palliative Thoracic Radiotherapy for NonSmall Cell Lung Cancer
Loading...
Embargo End Date
ICR Authors
Authors
Kumar, Rajiv
Document Type
Thesis or Dissertation
Date
2019-01-01